The abstracts of the CTAD are available in PDF format, you can download them on

this link

The abstracts of the ICFSR are available in PDF format, you can download them on this link

this link

The abstracts of the ICFSR are available in PDF format, you can download them on this link

this link

AlzheimerResearch & ScienceSubscriptionResearch & Science

Plasma biomarker for Alzheimer’s disease: Are we ready now for clinical practice and drug trials?

This is a restricted content for our subscribers.

Research & Science What Have We Learned from Recent Alzheimer’s Trials? Perspective of the CTAD Task Force

Although the results were disappointing from two recent clinical trials of amyloid-targeting drugs in mild-to-moderate AD, the trials provided information that will be important for future studies, according to the EU-US CTAD Task Force, which met in November 2017 to… Continue Reading →

Research & Science A new large trial in Alzheimer’s disease Published in May 2018 in the NEJM

Verubecestat is an oral BACE-1 inhibitor that reduces the Aβ level in the cerebrospinal fluid of patients with Alzheimer’s disease. Authors  conducted a randomized, double-blind, placebo-controlled, 78-week trial to evaluate verubecestat at doses of 12 mg and 40 mg per… Continue Reading →

© 2018 Aging-news — Powered by WordPress

Theme inspired by Anders NorenUp ↑